These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8463315)

  • 41. Glycosylation of Asn397 or Asn418 is required for normal insulin receptor biosynthesis and processing.
    Bastian W; Zhu J; Way B; Lockwood D; Livingston J
    Diabetes; 1993 Jul; 42(7):966-74. PubMed ID: 8513978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human insulin-degrading enzyme working mechanism.
    Amata O; Marino T; Russo N; Toscano M
    J Am Chem Soc; 2009 Oct; 131(41):14804-11. PubMed ID: 19785409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The insulysin (insulin degrading enzyme) enigma.
    Hersh LB
    Cell Mol Life Sci; 2006 Nov; 63(21):2432-4. PubMed ID: 16952049
    [No Abstract]   [Full Text] [Related]  

  • 44. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
    Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
    Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arg(1098) is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity.
    Liu X; Fernandez M; Wouters MA; Heyberger S; Husain A
    J Biol Chem; 2001 Sep; 276(36):33518-25. PubMed ID: 11432860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Covalent linkage of 125I-insulin to a cytosolic insulin-degrading enzyme.
    Shii K; Baba S; Yokono K; Roth RA
    J Biol Chem; 1985 Jun; 260(11):6503-6. PubMed ID: 3888982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-directed alterations to the geometry of the aspartate transcarbamoylase zinc domain: selective alteration to regulation by heterotropic ligands, isoelectric point, and stability in urea.
    Strang CJ; Wales ME; Brown DM; Wild JR
    Biochemistry; 1993 Apr; 32(16):4156-67. PubMed ID: 8476846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of site-directed mutagenesis of the surface residues Gln128 and Gln225 of thermolysin on its catalytic activity.
    Tatsumi C; Hashida Y; Yasukawa K; Inouye K
    J Biochem; 2007 Jun; 141(6):835-42. PubMed ID: 17405799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The C-terminal part of diacylglycerol kinase alpha lacking zinc fingers serves as a catalytic domain.
    Sakane F; Kai M; Wada I; Imai S; Kanoh H
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):583-90. PubMed ID: 8809050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin.
    Garcia JV; Gehm BD; Rosner MR
    J Cell Biol; 1989 Sep; 109(3):1301-7. PubMed ID: 2670957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
    Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Amano K; Sakamoto T; Kawase Y; Akiyama H; Nagata M
    Biochem Biophys Res Commun; 1988 Jan; 150(2):605-14. PubMed ID: 3277630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families.
    Kim M; Hersh LB; Leissring MA; Ingelsson M; Matsui T; Farris W; Lu A; Hyman BT; Selkoe DJ; Bertram L; Tanzi RE
    J Biol Chem; 2007 Mar; 282(11):7825-32. PubMed ID: 17244626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-covalent interaction of ubiquitin with insulin-degrading enzyme.
    Saric T; Müller D; Seitz HJ; Pavelic K
    Mol Cell Endocrinol; 2003 Jun; 204(1-2):11-20. PubMed ID: 12850277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The phylogenetically conserved histidines of Escherichia coli porphobilinogen synthase are not required for catalysis.
    Mitchell LW; Volin M; Jaffe EK
    J Biol Chem; 1995 Oct; 270(41):24054-9. PubMed ID: 7592604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
    Duckworth WC; Hamel FG; Bennett R; Ryan MP; Roth RA
    J Biol Chem; 1990 Feb; 265(5):2984-7. PubMed ID: 1689296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
    Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asp333, Asp495, and His523 form the catalytic triad of rat soluble epoxide hydrolase.
    Arand M; Wagner H; Oesch F
    J Biol Chem; 1996 Feb; 271(8):4223-9. PubMed ID: 8626766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineering of the pH-dependence of thermolysin activity as examined by site-directed mutagenesis of Asn112 located at the active site of thermolysin.
    Kusano M; Yasukawa K; Hashida Y; Inouye K
    J Biochem; 2006 Jun; 139(6):1017-23. PubMed ID: 16788052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Site-directed mutagenesis of histidine-90 in Escherichia coli L-threonine dehydrogenase alters its substrate specificity.
    Johnson AR; Dekker EE
    Arch Biochem Biophys; 1998 Mar; 351(1):8-16. PubMed ID: 9500838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition.
    Li P; Kuo WL; Yousef M; Rosner MR; Tang WJ
    Biochem Biophys Res Commun; 2006 May; 343(4):1032-7. PubMed ID: 16574064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.